Paper28523352
Interim heterogeneity changes measured using entropy texture features on T2-weighted MRI at 3.0 T are associated with pathological response to neoadjuvant chemotherapy in primary breast cancer.
Henderson S and 7 others. Eur Radiol, 2017. Cited by 54 papers, by iCite.
Cite this record
ConductScience Library. Interim heterogeneity changes measured using entropy texture features on T2-weighted MRI at 3.0 T are associated with pathological response to neoadjuvant chemotherapy in primary breast cancer. Papers, record 28523352. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28523352
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Interim heterogeneity changes measured using entropy texture features on T2-weighted MRI at 3.0 T are associated with pathological response to neoadjuvant chemotherapy in primary breast cancer.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Breast | Major topic |
| Breast Neoplasms | Major topic |
| Magnetic Resonance Imaging | Major topic |
| Adult | |
| Aged | |
| Female | |
| Humans | |
| Middle Aged | |
| Neoadjuvant Therapy | |
| ROC Curve | |
| Retrospective Studies |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22086561 | Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival. | Eur Radiol | 2012 | https://conductscience.org/library/papers/22086561 | PubMed |
| 2 | 23436342 | Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017. | Cancer | 2013 | https://conductscience.org/library/papers/23436342 | PubMed |
| 3 | 10542352 | Texture analysis of spinal cord pathology in multiple sclerosis. | Magn Reson Med | 1999 | https://conductscience.org/library/papers/10542352 | PubMed |
| 4 | 15908529 | MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. | AJR Am J Roentgenol | 2005 | https://conductscience.org/library/papers/15908529 | PubMed |
| 5 | 26663695 | Breast MRI radiogenomics: Current status and research implications. | J Magn Reson Imaging | 2016 | https://conductscience.org/library/papers/26663695 | PubMed |
| 6 | 17785706 | Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. | J Clin Oncol | 2007 | https://conductscience.org/library/papers/17785706 | PubMed |
| 7 | 9400844 | Multifeature analysis of Gd-enhanced MR images of breast lesions. | J Magn Reson Imaging | 1997 | https://conductscience.org/library/papers/9400844 | PubMed |
| 8 | 21220595 | Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/21220595 | PubMed |
| 9 | 19945302 | Characterization of breast cancer types by texture analysis of magnetic resonance images. | Acad Radiol | 2010 | https://conductscience.org/library/papers/19945302 | PubMed |
| 10 | 24840393 | Dynamic contrast-enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. | NMR Biomed | 2014 | https://conductscience.org/library/papers/24840393 | PubMed |
| 11 | 22623692 | Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL. | Radiology | 2012 | https://conductscience.org/library/papers/22623692 | PubMed |
| 12 | 22034451 | Texture analysis of the brain: from animal models to human applications. | Dialogues Clin Neurosci | 2004 | https://conductscience.org/library/papers/22034451 | PubMed |
| 13 | 23093486 | Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? | Insights Imaging | 2012 | https://conductscience.org/library/papers/23093486 | PubMed |
| 14 | 22198468 | Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657). | Breast Cancer Res Treat | 2012 | https://conductscience.org/library/papers/22198468 | PubMed |
| 15 | 26971432 | Multi-parametric MRI in the early prediction of response to neo-adjuvant chemotherapy in breast cancer: Value of non-modelled parameters. | Eur J Radiol | 2016 | https://conductscience.org/library/papers/26971432 | PubMed |
| 16 | 24529560 | Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. | Lancet | 2014 | https://conductscience.org/library/papers/24529560 | PubMed |
| 17 | 15556588 | Texture analysis of medical images. | Clin Radiol | 2004 | https://conductscience.org/library/papers/15556588 | PubMed |
| 18 | 14673041 | Is surgery necessary after complete clinical remission following neoadjuvant chemotherapy for early breast cancer? | J Clin Oncol | 2003 | https://conductscience.org/library/papers/14673041 | PubMed |
| 19 | 19440188 | I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy. | Clin Pharmacol Ther | 2009 | https://conductscience.org/library/papers/19440188 | PubMed |
| 20 | 26243303 | Texture analysis on MR images helps predicting non-response to NAC in breast cancer. | BMC Cancer | 2015 | https://conductscience.org/library/papers/26243303 | PubMed |
Cited by40
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42225584 | Refining the Predictive Role of T2-Weighted Imaging Features in Breast Cancer: A Hypothesis Linking Tumor Characteristics to Extreme Chemoresistance. | Korean J Radiol | 2026 | https://conductscience.org/library/papers/42225584 | PubMed |
| 41030906 | Multimodal Magnetic Resonance Imaging and Radiomics in Brucella Spondylitis: Diagnostic Applications and Differential Diagnosis. | J Multidiscip Healthc | 2025 | https://conductscience.org/library/papers/41030906 | PubMed |
| 37835774 | Machine Learning Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy for ER+HER2- Breast Cancer: Integrating Tumoral and Peritumoral MRI Radiomic Features. | Diagnostics (Basel) | 2023 | https://conductscience.org/library/papers/37835774 | PubMed |
| 37534540 | The use of radiomics in magnetic resonance imaging for the pre-treatment characterisation of breast cancers: A scoping review. | J Med Radiat Sci | 2023 | https://conductscience.org/library/papers/37534540 | PubMed |
| 36831368 | Assessment of Response to Neoadjuvant Systemic Treatment in Triple-Negative Breast Cancer Using Functional Tumor Volumes from Longitudinal Dynamic Contrast-Enhanced MRI. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36831368 | PubMed |
| 36802982 | Radiomic analysis in contrast-enhanced mammography using a multivendor data set: accuracy of models according to segmentation techniques. | Br J Radiol | 2023 | https://conductscience.org/library/papers/36802982 | PubMed |
| 36418622 | Machine learning on MRI radiomic features: identification of molecular subtype alteration in breast cancer after neoadjuvant therapy. | Eur Radiol | 2023 | https://conductscience.org/library/papers/36418622 | PubMed |
| 36414984 | An integrated deep learning model for the prediction of pathological complete response to neoadjuvant chemotherapy with serial ultrasonography in breast cancer patients: a multicentre, retrospective study. | Breast Cancer Res | 2022 | https://conductscience.org/library/papers/36414984 | PubMed |
| 36202934 | Robustness of radiomics to variations in segmentation methods in multimodal brain MRI. | Sci Rep | 2022 | https://conductscience.org/library/papers/36202934 | PubMed |
| 36006071 | Performance of Machine Learning and Texture Analysis for Predicting Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer with 3T MRI. | Tomography | 2022 | https://conductscience.org/library/papers/36006071 | PubMed |
| 35884576 | Delta-Radiomics Based on Dynamic Contrast-Enhanced MRI Predicts Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35884576 | PubMed |
| 35849178 | Changes in kinetic heterogeneity of breast cancer via computer-aided diagnosis on MRI predict the pathological response to neoadjuvant systemic therapy. | Eur Radiol | 2023 | https://conductscience.org/library/papers/35849178 | PubMed |
| 35314626 | Ipsilateral Recurrence of DCIS in Relation to Radiomics Features on Contrast Enhanced Breast MRI. | Tomography | 2022 | https://conductscience.org/library/papers/35314626 | PubMed |
| 34858821 | The Potential Value of Texture Analysis Based on Dynamic Contrast-Enhanced MR Images in the Grading of Breast Phyllode Tumors. | Front Oncol | 2021 | https://conductscience.org/library/papers/34858821 | PubMed |
| 34829433 | Radiomics Analysis of Multi-Phase DCE-MRI in Predicting Tumor Response to Neoadjuvant Therapy in Breast Cancer. | Diagnostics (Basel) | 2021 | https://conductscience.org/library/papers/34829433 | PubMed |
| 34826254 | Association between breast cancer's prognostic factors and 3D textural features of non-contrast-enhanced T1 weighted breast MRI. | Br J Radiol | 2022 | https://conductscience.org/library/papers/34826254 | PubMed |
| 34704213 | Radiomics in breast MRI: current progress toward clinical application in the era of artificial intelligence. | Radiol Med | 2022 | https://conductscience.org/library/papers/34704213 | PubMed |
| 34671399 | Machine Learning: Applications and Advanced Progresses of Radiomics in Endocrine Neoplasms. | J Oncol | 2021 | https://conductscience.org/library/papers/34671399 | PubMed |
| 34503081 | Radiomics of MRI for the Prediction of the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Single Referral Centre Analysis. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34503081 | PubMed |
| 34262646 | MRI texture features from tumor core and margin in the prediction of response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. | Oncotarget | 2021 | https://conductscience.org/library/papers/34262646 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CLEC3B | 7123 | PubTator's text mining | https://conductscience.org/library/genes/7123 | NCBI Gene |
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| EREG | 2069 | PubTator's text mining | https://conductscience.org/library/genes/2069 | NCBI Gene |
| NR4A1 | 3164 | PubTator's text mining | https://conductscience.org/library/genes/3164 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28523352
GET https://conductscience.org/api/papers/v1/28523352/references?page=2